{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:46:23Z","timestamp":1789991183375,"version":"4.0.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20171173"],"award-info":[{"award-number":["BK20171173"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012218","name":"Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy","doi-asserted-by":"publisher","award":["XZSYSKF2020023"],"award-info":[{"award-number":["XZSYSKF2020023"]}],"id":[{"id":"10.13039\/501100012218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate the relationship between TET2 expression and endometrial cancer\u2019s clinicopathological features and prognosis, and the effect of metformin on TET2 and 5hmC levels in endometrial cancer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical significance of TET2 expression in endometrial carcinoma was analyzed from TCGA public database. Eighty-eight patients with endometrial cancer and 20 patients with normal proliferative endometrium were enrolled in this study. TET2 and 5hmC were respectively detected by Immunohistochemistry and ELISA in endometrial tissues. Kaplan-Meier and Cox proportional hazard regression models were used to analyze relationships between TET2 and 5hmC and the overall survival of EC patients. Endometrial cell proliferation was assessed after TET2 gene knockdown. Western blotting and real-time PCR were used to detect the effect of metformin on TET2 expression and to explore whether AMPK is involved in metformin-mediated TET2 regulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The clinical significance of expression of TET2 in endometrial cancer from TCGA public database confirmed that TET2 expression was significantly down-regulated in cancer samples and TET2 expression was also significantly different among different histopathological samples and TET2 is down-regulated in advanced, high-grade, and relapsed endometrial carcinoma tissues(P&amp;lt;0.05). Immunohistochemical analysis showed that TET2 and 5hmC levels were significantly lower in endometrial adenocarcinoma(P&amp;lt;0.05). TET2 expression was correlated with the degree of EC differentiation (P &amp;lt; 0.05). 5hmC levels were associated with clinical stage, differentiation, the depth of myometrial invasion, and lymph node metastasis (P &amp;lt; 0.05). The mean survival time of patients with negative staining for TET2 and 5hmC was shorter than that of patients with positive staining for both markers (P&amp;lt;0.05). Multivariate Cox regression analysis showed that TET2 expression was an independent risk factor for prognosis in patients with endometrial adenocarcinoma (HR = 14.520, 95% CI was 1.From 060 to 198.843, P = 0.045). siRNA-mediated TET2 knockdown increased the proliferation of EC cells. Metformin increased the levels of TET2 and 5hmC in EC cells. AMPK was involved in the regulation of TET2 by metformin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TET2 may play an important role in EC development and may be a prognostic marker. Moreover, TET2 may be involved in a novel mechanism by which metformin inhibits EC cell proliferation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.856707","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T05:50:10Z","timestamp":1649656210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism"],"prefix":"10.3389","volume":"12","author":[{"given":"Jingbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer Statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation Distinguishes Genes of Some Human Cancers From Their Normal Counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083558","article-title":"Induction of Tumors in Mice by Genomic Hypomethylation","volume":"300","author":"Gaudet","year":"2003","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3130","article-title":"A Decade of Exploring the Cancer Epigenome - Biological and Translational Implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ceb.2015.10.009","article-title":"DNA Methylation and Hydroxymethylation in Hematologic Differentiation and Transformation","volume":"37","author":"Ko","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.156","article-title":"TET1 is a DNA-Binding Protein That Modulates DNA Methylation and Gene Transcription via Hydroxylation of 5-Methylcytosine","volume":"20","author":"Zhang","year":"2010","journal-title":"Cell Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1210944","article-title":"Tet-Mediated Formation of 5-Carboxylcytosine and its Excision by TDG in Mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13148-019-0675-4","article-title":"Epigenetics in Cancer Therapy and Nanomedicine","volume":"11","author":"Roberti","year":"2019","journal-title":"Clin Epigenet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.67","article-title":"Tumor Development is Associated With Decrease of TET Gene Expression and 5-Methylcytosine Hydroxylation","volume":"32","author":"Yang","year":"2013","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.316","article-title":"Global 5-Hydroxymethylcytosine Content Is Significantly Reduced in Tissue Stem\/Progenitor Cell Compartments and in Human Cancers","volume":"2","author":"Haffner","year":"2011","journal-title":"Oncotarget"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.6.10994","article-title":"Metformin and Cancer: Doses, Mechanisms and the Dandelion and Hormetic Phenomena","volume":"9","author":"Martin-Castillo","year":"2010","journal-title":"Cell Cycle"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0350-5","article-title":"Glucose-Regulated Phosphorylation of TET2 by AMPK Reveals a Pathway Linking Diabetes to Cancer","volume":"559","author":"Wu","year":"2018","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-0760(03)00066-9","article-title":"The Effects of Estradiol and Selective Estrogen Receptor Modulators on Gene Expression and Messenger RNA Stability in Immortalized Sheep Endometrial Stromal Cells and Human Endometrial Adenocarcinoma Cells","volume":"84","author":"Farnell","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1210597","article-title":"Tet Proteins can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA Methylation: Islands, Start Sites, Gene Bodies and Beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat Rev Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.061606.095816","article-title":"Cancer Epigenetics: Modifications, Screening, and Therapy","volume":"59","author":"Gal-Yam","year":"2008","journal-title":"Annu Rev Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.10","article-title":"Molecular Profiling of Chronic Myelomonocytic Leukemia Reveals Diverse Mutations in <80% of Patients With TET2 and EZH2 Being of High Prognostic Relevance","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Melanoma","volume":"150","author":"Lian","year":"2012","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.224","article-title":"Loss of 5-Hydroxymethylcytosine Correlates With Increasing Morphologic Dysplasia In Melanocytic Tumors","volume":"27","author":"Larson","year":"2014","journal-title":"Mod Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-33-32","article-title":"High Expression of 5-Hydroxymethylcytosine and Isocitrate Dehydrogenase 2 Is Associated With Favorable Prognosis After Curative Resection of Hepatocellular Carcinoma","volume":"33","author":"Liu","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.193938","article-title":"Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine in Genomic DNA From Hepatocellular Carcinoma Tissues by Capillary Hydrophilic-Interaction Liquid Chromatography\/Quadrupole TOF Mass Spectrometry","volume":"59","author":"Chen","year":"2013","journal-title":"Clin Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2023","article-title":"5-Hydroxymethylcytosine is Strongly Depleted in Human Cancers But its Levels do Not Correlate With IDH1 Mutations","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1242\/dev.070771","article-title":"Tet Family Proteins and 5-Hydroxymethylcytosine in Development and Disease","volume":"139","author":"Tan","year":"2012","journal-title":"Development"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.9b00012","article-title":"Idarubicin Stimulates Cell Cycle- and TET2-Dependent Oxidation of DNA 5-Methylcytosine in Cancer Cells","volume":"32","author":"Zhong","year":"2019","journal-title":"Chem Res Toxicol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30146","article-title":"Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.07.013","article-title":"Decreased TET2 Gene Expression During Chronic Myeloid Leukemia Progression","volume":"35","author":"Albano","year":"2011","journal-title":"Leuk Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-339747","article-title":"TET2 Mutation Is an Unfavorable Prognostic Factor in Acute Myeloid Leukemia Patients With Intermediate-Risk Cytogenetics","volume":"118","author":"Chou","year":"2011","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature09586","article-title":"Impaired Hydroxylation of 5-Methylcytosine in Myeloid Cancers With Mutant TET2","volume":"468","author":"Ko","year":"2010","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.10984","article-title":"DNA Methylation Machinery in the Endometrium and Endometrial Cancer","volume":"36","author":"Caplakova","year":"2016","journal-title":"Anticancer Res"},{"key":"B31","first-page":"1014","article-title":"Epigenetic Modifications and Carcinogenesis of Human Endometrial Cancer","volume":"1","author":"Ma","year":"2014","journal-title":"Austin J Clin Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13059-015-0605-5","article-title":"5-Hydroxymethylcytosine Marks Promoters in Colon That Resist DNA Hypermethylation in Cancer","volume":"16","author":"Uribe-Lewis","year":"2015","journal-title":"Genome Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6877","article-title":"Role of Metformin in Inhibiting Estrogen-Induced Proliferation and Regulating ERalpha and ERbeta Expression in Human Endometrial Cancer Cells","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nm0216-217b","article-title":"Corrigendum: Metformin Activates a Duodenal Ampk-Dependent Pathway to Lower Hepatic Glucose Production in Rats","volume":"22","author":"Duca","year":"2016","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.09.024","article-title":"Metformin is a Potent Inhibitor of Endometrial Cancer Cell Proliferation\u2013Implications for a Novel Treatment Strategy","volume":"116","author":"Cantrell","year":"2010","journal-title":"Gynecol Oncol"},{"key":"B36","article-title":"[Metformin\u2013new Treatment Strategies for Gynecologic Neoplasms]","volume":"70","author":"Milewicz","year":"2013","journal-title":"Przegl Lek"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.856707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T05:50:15Z","timestamp":1649656215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.856707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":36,"alternative-id":["10.3389\/fonc.2022.856707"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.856707","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"article-number":"856707"}}